A Phase III, Multi-center, Open-label Trial to Investigate the Impact of a Treat, Counsel and Cure Strategy in Men Who Have Sex With Men With Hepatitis C Infection in the Swiss HIV Cohort Study
Phase of Trial: Phase III
Latest Information Update: 07 Mar 2018
At a glance
- Drugs Elbasvir/grazoprevir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 07 Mar 2018 Status changed to completed, according to results presented at the 25th Conference on Retroviruses and Opportunistic Infections.
- 07 Mar 2018 Results presented at the 25th Conference on Retroviruses and Opportunistic Infections.
- 09 Oct 2017 Planned End Date changed from 1 Apr 2017 to 1 Apr 2018.